Redox Regulation of Insulin Degradation by Insulin-degrading Enzyme

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 Mar 31

PMID 21448434

Citations 15

Authors

Crystal M Cordes

Robert G Bennett

Gerri L Siford

Frederick G Hamel

Affiliations

Soon will be listed here.

Abstract

Insulin-degrading enzyme (IDE) is a thiol sensitive peptidase that degrades insulin and amyloid β, and has been linked to type 2 diabetes mellitus and Alzheimer's disease. We examined the thiol sensitivity of IDE using S-nitrosoglutathione, reduced glutathione, and oxidized glutathione to distinguish the effects of nitric oxide from that of the redox state. The in vitro activity of IDE was studied using either partially purified cytosolic enzyme from male Sprague-Dawley rats, or purified rat recombinant enzyme. We confirm that nitric oxide inhibits the degrading activity of IDE, and that it affects proteasome activity through this interaction with IDE, but does not affect the proteasome directly. Oxidized glutathione inhibits IDE through glutathionylation, which was reversible by dithiothreitol but not by ascorbic acid. Reduced glutathione had no effect on IDE, but reacted with partially degraded insulin to disrupt its disulfide bonds and accelerate its breakdown to trichloroacetic acid soluble fragments. Our results demonstrate the sensitivity of insulin degradation by IDE to the redox environment and suggest another mechanism by which the cell's oxidation state may contribute to the development of, and the link between, type 2 diabetes and Alzheimer's disease.

Citing Articles

The Promising Potency of Sodium-Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients.

Zhang Y, Liao X, Xu J, Yin J, Li S, Li M Biomedicines. 2025; 12(12.

PMID: 39767690 PMC: 11673520. DOI: 10.3390/biomedicines12122783.

Sustained feeding of a diet high in fat resulted in a decline in the liver's insulin-degrading enzyme levels in association with the induction of oxidative and endoplasmic reticulum stress in adult male rats: Evaluation of 4-phenylbutyric acid.

Binayi F, Saeidi B, Farahani F, Sadat Izadi M, Eskandari F, Azarkish F Heliyon. 2024; 10(12):e32804.

PMID: 38975085 PMC: 11226834. DOI: 10.1016/j.heliyon.2024.e32804.

αB-Crystallin Peptide Fused with Elastin-like Polypeptide: Intracellular Activity in Retinal Pigment Epithelial Cells Challenged with Oxidative Stress.

Attia S, Truong A, Phan A, Lee S, Abanmai M, Markanovic M Antioxidants (Basel). 2023; 12(10).

PMID: 37891896 PMC: 10604459. DOI: 10.3390/antiox12101817.

Neuronal Nitric Oxide Synthase and Post-Translational Modifications in the Development of Central Nervous System Diseases: Implications and Regulation.

Maccallini C, Amoroso R Molecules. 2023; 28(18).

PMID: 37764469 PMC: 10538099. DOI: 10.3390/molecules28186691.

The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease.

Barone E, Di Domenico F, Perluigi M, Butterfield D Free Radic Biol Med. 2021; 176:16-33.

PMID: 34530075 PMC: 8595768. DOI: 10.1016/j.freeradbiomed.2021.09.006.

References

Tao L, English A . Protein S-glutathiolation triggered by decomposed S-nitrosoglutathione. Biochemistry. 2004; 43(13):4028-38. DOI: 10.1021/bi035924o. View

Martinez-Ruiz A, Lamas S . Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc Res. 2007; 75(2):220-8. DOI: 10.1016/j.cardiores.2007.03.016. View

Nikoshkov A, Kamel A, Fernstrom M, Zierath J, Norgren S, Luthman H . Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum Mol Genet. 2000; 9(14):2149-58. DOI: 10.1093/hmg/9.14.2149. View

Hamel F, Peavy D, Ryan M, Duckworth W . HPLC analysis of insulin degradation products from isolated hepatocytes. Effects of inhibitors suggest intracellular and extracellular pathways. Diabetes. 1987; 36(6):702-8. DOI: 10.2337/diab.36.6.702. View

Hamel F, Peavy D, Ryan M, Duckworth W . High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease. Endocrinology. 1986; 118(1):328-33. DOI: 10.1210/endo-118-1-328. View

Jaffrey S, Snyder S . The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE. 2001; 2001(86):pl1. DOI: 10.1126/stke.2001.86.pl1. View

Duckworth W, Heinemann M, Kitabchi A . Purification of insulin-specific protease by affinity chromatography. Proc Natl Acad Sci U S A. 1972; 69(12):3698-702. PMC: 389852. DOI: 10.1073/pnas.69.12.3698. View

Clancy R, Levartovsky D, Yegudin J, Abramson S . Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc Natl Acad Sci U S A. 1994; 91(9):3680-4. PMC: 43645. DOI: 10.1073/pnas.91.9.3680. View

Hamel F, Bennett R, Duckworth W . Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme. Endocrinology. 1998; 139(10):4061-6. DOI: 10.1210/endo.139.10.6256. View

10.

Fujimoto M, Shimizu N, Kunii K, Martyn J, Ueki K, Kaneki M . A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes. 2005; 54(5):1340-8. DOI: 10.2337/diabetes.54.5.1340. View

11.

Karamohamed S, Demissie S, Volcjak J, Liu C, Heard-Costa N, Liu J . Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes. 2003; 52(6):1562-7. DOI: 10.2337/diabetes.52.6.1562. View

12.

Malito E, Ralat L, Manolopoulou M, Tsay J, Wadlington N, Tang W . Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme. Biochemistry. 2008; 47(48):12822-34. PMC: 2652632. DOI: 10.1021/bi801192h. View

13.

Song E, Juliano M, Juliano L, Fried M, Wagner S, Hersh L . ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety. J Biol Chem. 2004; 279(52):54216-20. DOI: 10.1074/jbc.M411177200. View

14.

Shinall H, Song E, Hersh L . Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. Biochemistry. 2005; 44(46):15345-50. DOI: 10.1021/bi050650l. View

15.

Hamel F, Upward J, Bennett R . In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology. 2003; 144(6):2404-8. DOI: 10.1210/en.2002-0007. View

16.

Furukawa Y, Shimada T, Furuta H, Matsuno S, Kusuyama A, Doi A . Polymorphisms in the IDE-KIF11-HHEX gene locus are reproducibly associated with type 2 diabetes in a Japanese population. J Clin Endocrinol Metab. 2007; 93(1):310-4. DOI: 10.1210/jc.2007-1029. View

17.

Ralat L, Ren M, Schilling A, Tang W . Protective role of Cys-178 against the inactivation and oligomerization of human insulin-degrading enzyme by oxidation and nitrosylation. J Biol Chem. 2009; 284(49):34005-18. PMC: 2797171. DOI: 10.1074/jbc.M109.030627. View

18.

Cordes C, Bennett R, Siford G, Hamel F . Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation. Biochem Pharmacol. 2009; 77(6):1064-73. DOI: 10.1016/j.bcp.2008.12.006. View

19.

Craft S . Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res. 2007; 4(2):147-52. DOI: 10.2174/156720507780362137. View

20.

Duckworth W, Hamel F, Liepnieks J, Frank B, Yagil C, Rabkin R . High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line. Endocrinology. 1988; 123(6):2701-8. DOI: 10.1210/endo-123-6-2701. View